On the quest for mescaline

Francesco Zamberlan

DOI: https://doi.org/10.1038/s41589-024-01675-5

IF: 14.8

2024-06-25

Nature Chemical Biology

Abstract:Mescaline, a substituted phenethylamine protoalkaloid, is the primary hallucinogenic compound in psychedelic cacti such as Lophophora williamsii (commonly known as peyote). The mescaline biosynthetic pathway has been postulated for half a century; it entails hydroxylation and decarboxylation of l -tyrosine to dopamine through tyramine or l- 3,4-dihydroxyphenylalanine ( l -DOPA), followed by a series of O -methylations and hydroxylations to mescaline. However, the specific enzymes responsible for these transformations remained unknown. Now, Berman et al. have identified the enzymes responsible for the six steps of mescaline biosynthesis. After de novo whole-genome and transcriptome sequencing and profiling, the team examined where biosynthesis occurs in the plant, finding that mescaline and related phenethylamines are produced in the button skin, the top of the cactus. They identified LwTyDC2 as the decarboxylase responsible for the initial transformation of l -tyrosine into tyramine and l -DOPA into dopamine, while LwCYP76AD131, a cytochrome P450 enzyme, catalyzed the meta -hydroxylations of tyramine to dopamine. Subsequently, N -methyltransferase 2, termed LwNMT1, was found to be responsible for N -methylating and N,N -dimethylating all intermediates of the mescaline pathway, showing a broad substrate tolerance. LwOMT1 and LwOMT5 O -methylated the two meta -hydroxyl groups and produced mescaline in vitro, while LwOMT10 and LwOMT11 targeted the para -hydroxyl groups of other pathway metabolites. Molecular modelling of the different methyltransferase enzymes shed light on their regioselectivity. Reconstitution of the pathway in Saccharomyces cerevisiae and Nicotiana benthamiana stopped short of producing mescaline in vivo.

biochemistry & molecular biology